Phase III randomized trial of standard fractionation radiotherapy (SFX) with concurrent cisplatin (CIS) versus accelerated fractionation radiotherapy (AFX) with panitumumab (PMab) in patients (pts) with locoregionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): NCIC Clinical Trials Group HN.6 trial.

Authors

Siu LL; Waldron JN; Chen BE; Winquist E; Wright JR; Nabid A; Hay JH; Ringash J; Liu G; Johnson A

pp. 6000-6000

American Society of Clinical Oncology (ASCO)

May 20, 2015

10.1200/jco.2015.33.15_suppl.6000

Journal of Clinical Oncology

15_suppl

0732-183X

James Wright

Martin Chasen